Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pauline Wales

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Parkinson'S Disease|November 26, 2013
Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegenerationPauline Wales, Raquel Pinho, Diana F Lázaro, et al.
Annals of Neurology|March 29, 2013
β-synuclein aggregates and induces neurodegeneration in dopaminergic neuronsGrit Taschenberger, Johan Toloe, Julia Tereshchenko, et al.
Developmental Cell|December 4, 2019
Age-Onset Phosphorylation of a Minor Actin Variant Promotes Intestinal Barrier DysfunctionNathan Egge, Sonja L B Arneaud, Pauline Wales, et al.
Human Molecular Genetics|April 4, 2017
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damageIsabel Paiva, Raquel Pinho, Maria Angeliki Pavlou, et al.
Nature Methods|August 12, 2020
Actin chromobody imaging reveals sub-organellar actin dynamicsCara R Schiavon, Tong Zhang, Bing Zhao, et al.
Plos One|January 22, 2015
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemiaXiqun Chen, Pauline Wales, Luisa Quinti, et al.
Plos One|December 29, 2017
Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Plos One|June 21, 2016
Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Elife|December 7, 2016
Calcium-mediated actin reset (CaAR) mediates acute cell adaptationsPauline Wales, Christian E Schuberth, Roland Aufschnaiter, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Parkinson'S Disease|November 26, 2013
Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegenerationPauline Wales, Raquel Pinho, Diana F Lázaro, et al.
Annals of Neurology|March 29, 2013
β-synuclein aggregates and induces neurodegeneration in dopaminergic neuronsGrit Taschenberger, Johan Toloe, Julia Tereshchenko, et al.
Developmental Cell|December 4, 2019
Age-Onset Phosphorylation of a Minor Actin Variant Promotes Intestinal Barrier DysfunctionNathan Egge, Sonja L B Arneaud, Pauline Wales, et al.
Human Molecular Genetics|April 4, 2017
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damageIsabel Paiva, Raquel Pinho, Maria Angeliki Pavlou, et al.
Nature Methods|August 12, 2020
Actin chromobody imaging reveals sub-organellar actin dynamicsCara R Schiavon, Tong Zhang, Bing Zhao, et al.
Plos One|January 22, 2015
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemiaXiqun Chen, Pauline Wales, Luisa Quinti, et al.
Plos One|December 29, 2017
Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Plos One|June 21, 2016
Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression ProfilesRaquel Pinho, Leonor C Guedes, Lilach Soreq, et al.
Elife|December 7, 2016
Calcium-mediated actin reset (CaAR) mediates acute cell adaptationsPauline Wales, Christian E Schuberth, Roland Aufschnaiter, et al.
Pageof 1